NVS-CECR2-1
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-110374-5 mg |
| CAS # | 1992047-61-6 |
| Pricing | 5 mg, USD $300.0 |
| Biological Activity | NVS-CECR2-1, a non-BET family Bromodomain (BRD) inhibitor, is a potent and selective cat eye syndrome chromosome region, candidate 2 (CECR2) inhibitor. NVS-CECR2-1 binds to CECR2 BRD with high affinity (IC50=47 nM; KD=80 nM). NVS-CECR2-1 exhibits cytotoxic activity and induces apoptosis against various cancer cells by targeting CECR2 as well as via CECR2-independent mechanism[1]. |
| Purity | ≥99.0% |
| MWt | 495.68 |
| Formula | C₂₇H₃₇N₅O₂S |